GUIDELINE ON SAFETY AND EFFICACY FOLLOW-UP AND RISK 6 MANAGEMENT OF ADVANCED THERAPY MEDICINAL PRODUCTS da Admin | Gen 25, 2018 | Regolatorio“http://www.ema.europa.eu”